Our experimental findings suggest that the anti-AD effects of BTHWD may be linked to PPARγ-mediated regulation of VLCFA degradation, glycerophospholipid synthesis, as well as the expression of fatty acid (FA)-related and glycerophospholipid-related genes, which exhibit synchronous changes with PPARγ gene expression. This evidence concerns the gene PPARG and Alzheimer disease.